Recent Updates
Recently added Catalysts
PROF Positive Sentiment

Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®

Monday, February 19, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Profound Medical Corp. has signed a co-development agreement with GE Healthcare to enhance access to its TULSA-PRO® system. This collaboration aims to expand the availability of Profound's incision-free therapies, which utilize advanced MRI and thermal ultrasound technology. The partnership is expected to bolster the company's market presence and improve patient outcomes.
Price reaction · baseline $8.5 (2024-02-16 close) · 16 other PROF headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Profound Medical expands access to its innovative TULSA-PRO® system.
  • Collaboration with GE Healthcare enhances provider reach.
  • Agreement supports the growth of incision-free therapies.

Full Press Release Details

TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that it has entered into a co-development agreement with GE Healthcare.

Frequently Asked Questions

What is the TULSA-PRO® system?

The TULSA-PRO® system is a customizable, incision-free therapy that combines MRI, thermal ultrasound, and temperature feedback for tissue ablation.

Who has Profound Medical partnered with?

Profound Medical has entered into a co-development agreement with GE Healthcare.

What is the goal of the agreement with GE Healthcare?

The agreement aims to expand provider access to the TULSA-PRO® system and enhance the reach of incision-free therapies.

What technology does TULSA-PRO® utilize?

TULSA-PRO® utilizes real-time MRI, thermal ultrasound, and closed-loop temperature feedback control.

ShareAdd on Google
Tags: PROF Viatris Investor Conferences Healthcare Profound Medical GE Healthcare TULSA-PRO incision-free therapies MRI
Last updated: Feb 19, 2024

Biotech snapshot

Cash runway
$38M liquidity · $4M/mo burn
~10 mo
Medium dilution risk